Notoginsenoside T2

2-[[17-[(E)-4-(3,3-dimethyloxiran-2-yl)-4-methoxybut-2-en-2-yl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

UWWGFPDRXDYTKI-NBVRZTHBSA-N CHEBI:176285 0 Reactome links 3 studies

3 Observed studies

3 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: UWWGFPDRXDYTKI-NBVRZTHBSA-N
InChI Key: UWWGFPDRXDYTKI-NBVRZTHBSA-N
IUPAC name: 2-[[17-[(E)-4-(3,3-dimethyloxiran-2-yl)-4-methoxybut-2-en-2-yl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Preferred name: Notoginsenoside T2
INN name: —
Synonym: —
ChEBI: CHEBI:176285

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles